Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach

Amitriptyline was first introduced as a medication to treat depression. Over time, this substance has been used to treat other conditions, such as gastrointestinal disorders, fibromyalgia, neuropathic pain, and analgesia, among others. However, there are no published studies that provide a broad view of the possible motivations that have led to changes in the use of amitriptyline. In this study, we have identified the landscape of use for amitriptyline based on knowledge mapping of the 100 most-cited articles about this drug. We searched Web of Science Core Collection without time and language restrictions. We obtained 14,446 results, but we only used the 100 most-cited articles that had amitriptyline as the object of study. We collected the following information from each article: authors, country of the corresponding authors, year of publication, citation count, citation density (number of citations per year), and keywords. In addition, we seek to map in the chosen articles study design and research findings. We found that since 1980, the use of amitriptyline has expanded beyond depression, moving to off-label use to treat a variety of diseases and conditions, including post-herpetic neuralgia, neuropathic pain, primary fibrosis, fibromyalgia, and migraine, can be considered a drug with more clinical applicability than its original clinical indication.

[1]  Hong Chen,et al.  Duloxetine and Amitriptyline Reduce Neuropathic Pain by Inhibiting Primary Sensory Input to Spinal Dorsal Horn Neurons via α1- and α2-Adrenergic Receptors. , 2023, ACS chemical neuroscience.

[2]  Michael A. Veronin,et al.  Tricyclic Antidepressants in Nociceptive and Neuropathic Pain: A Review of Their Analgesic Properties in Combination With Opioids , 2023, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.

[3]  P. Martins‐Júnior,et al.  Global research trends on maternal exposure to methylmercury and offspring health outcomes , 2022, Frontiers in Pharmacology.

[4]  R. Daniels,et al.  Classics in Chemical Neuroscience: Amitriptyline. , 2021, ACS chemical neuroscience.

[5]  Amitriptyline , 2019, Reactions Weekly.

[6]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[7]  H. Strothers Depression in the primary care setting. , 2019, Ethnicity & disease.

[8]  J. Ioannidis,et al.  Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. , 2018, Focus.

[9]  V. Pereira,et al.  A brief history of antidepressant drug development: from tricyclics to beyond ketamine , 2018, Acta Neuropsychiatrica.

[10]  Péter Jacsó,et al.  The scientometric portrait of Eugene Garfield through the free ResearcherID service from the Web of Science Core Collection of 67 million master records and 1.3 billion references , 2018, Scientometrics.

[11]  H. Obata Analgesic Mechanisms of Antidepressants for Neuropathic Pain , 2017, International journal of molecular sciences.

[12]  K. Lawson A Brief Review of the Pharmacology of Amitriptyline and Clinical Outcomes in Treating Fibromyalgia , 2017, Biomedicines.

[13]  Weishu Liu,et al.  The changing role of non‐English papers in scholarly communication: Evidence from Web of Science's three journal citation indexes , 2017, Learn. Publ..

[14]  P. Cuijpers,et al.  Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis , 2016, The Lancet.

[15]  K Longley,et al.  EULAR revised recommendations for the management of fibromyalgia , 2016, Annals of the rheumatic diseases.

[16]  J J Swen,et al.  Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants , 2013, Clinical pharmacology and therapeutics.

[17]  S. Leucht,et al.  Amitriptyline versus placebo for major depressive disorder. , 2012, The Cochrane database of systematic reviews.

[18]  S. Silberstein,et al.  Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults , 2012, Neurology.

[19]  W. Poewe,et al.  The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[20]  E. Feldman,et al.  Evidence-based guideline: Treatment of painful diabetic neuropathy , 2011, Neurology.

[21]  A. Serretti,et al.  Antidepressants and body weight: a comprehensive review and meta-analysis. , 2010, The Journal of clinical psychiatry.

[22]  P. Wiffen,et al.  Antidepressants for neuropathic pain: a Cochrane review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  Ed C. M. Noyons,et al.  A unified approach to mapping and clustering of bibliometric networks , 2010, J. Informetrics.

[24]  Ludo Waltman,et al.  Software survey: VOSviewer, a computer program for bibliometric mapping , 2009, Scientometrics.

[25]  A. May,et al.  EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force , 2009, European journal of neurology.

[26]  P. Moayyedi,et al.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis , 2008, Gut.

[27]  C. Loprinzi,et al.  Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. , 2008, European journal of cancer.

[28]  B. Pollock,et al.  Anticholinergic Activity of 107 Medications Commonly Used by Older Adults , 2008, Journal of the American Geriatrics Society.

[29]  M. Weller,et al.  Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis , 2008, Nature Medicine.

[30]  Matthew E Falagas,et al.  Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  K Longley,et al.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome , 2007, Annals of the rheumatic diseases.

[32]  P. Gillman Tricyclic antidepressant pharmacology and therapeutic drug interactions updated , 2007, British journal of pharmacology.

[33]  W. Kühn‐Velten,et al.  Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[34]  E. Begg,et al.  Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice , 2006, Pharmacological Reviews.

[35]  Lei Wang,et al.  Three options for citation tracking: Google Scholar, Scopus and Web of Science , 2006, Biomedical digital libraries.

[36]  E. Leinonen,et al.  A review of the pharmacological and clinical profile of mirtazapine. , 2006, CNS drug reviews.

[37]  S. Pandya,et al.  Practice parameter: Corticosteroid treatment of Duchenne dystrophy - Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society , 2006 .

[38]  A. May,et al.  EFNS guideline on the drug treatment of migraine – report of an EFNS task force , 2006, European journal of neurology.

[39]  R. Stafford,et al.  Off-label prescribing among office-based physicians. , 2006, Archives of internal medicine.

[40]  M. Moskowitz,et al.  Suppression of cortical spreading depression in migraine prophylaxis , 2006, Annals of neurology.

[41]  Roger B. Davis,et al.  Sham device v inert pill: randomised controlled trial of two placebo treatments , 2006, BMJ : British Medical Journal.

[42]  J. Mann,et al.  The medical management of depression. , 2005, The New England journal of medicine.

[43]  T. Nii,et al.  Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. , 2005, International journal of pharmaceutics.

[44]  Pal Pacher,et al.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? , 2004, Current pharmaceutical design.

[45]  H. Jick,et al.  Antidepressants and the risk of suicidal behaviors. , 2004, JAMA.

[46]  J Licinio,et al.  Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response , 2004, Molecular Psychiatry.

[47]  J. Duby,et al.  Diabetic neuropathy: an intensive review. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[48]  Christine Frahnert,et al.  Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[49]  S. Ashwal,et al.  CME Practice parameter : Evaluation of children and adolescents with recurrent headaches Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society , 2002 .

[50]  H. Karadag,et al.  Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats , 2002, Neuroscience Letters.

[51]  Karthik Venkatakrishnan,et al.  Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models , 2001, Journal of clinical pharmacology.

[52]  A. Rice,et al.  Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study , 2001, PAIN.

[53]  K. Holroyd,et al.  Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. , 2001, JAMA.

[54]  V. Setola,et al.  Discovery of a novel member of the histamine receptor family. , 2001, Molecular pharmacology.

[55]  E. Richelson,et al.  Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. , 2000, Life sciences.

[56]  M. Fava,et al.  Weight gain and antidepressants. , 2000, The Journal of clinical psychiatry.

[57]  L. Bendtsen Central Sensitization in Tension-Type Headache—Possible Pathophysiological Mechanisms , 2000, Cephalalgia : an international journal of headache.

[58]  I. Anderson,et al.  Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. , 2000, Journal of affective disorders.

[59]  H. Vedder,et al.  Cytokine Production and Treatment Response in Major Depressive Disorder , 2000, Neuropsychopharmacology.

[60]  P. Keck,et al.  Antidepressant treatment of fibromyalgia. A meta-analysis and review. , 2000, Psychosomatics.

[61]  S. Leckband,et al.  Randomized Double-blind Study Comparing the Efficacy of Gabapentin With Amitriptyline on Diabetic Peripheral Neuropathy Pain , 1999 .

[62]  A. Staiano,et al.  Childhood functional gastrointestinal disorders , 1999, Gut.

[63]  J. Teasdale,et al.  Prevention of relapse in residual depression by cognitive therapy: a controlled trial. , 1999, Archives of general psychiatry.

[64]  C. Sánchez,et al.  Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding , 1999, Cellular and Molecular Neurobiology.

[65]  S. McCleary,et al.  Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat , 1999, Pain.

[66]  W A Ray,et al.  Antidepressants and the risk of falls among nursing home residents. , 1998, The New England journal of medicine.

[67]  F. Guengerich,et al.  Cooperativity in oxidations catalyzed by cytochrome P450 3A4. , 1997, Biochemistry.

[68]  H. J. McQuay,et al.  A systematic review of antidepressants in neuropathic pain , 1996, Pain.

[69]  C. Schmid,et al.  A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. , 1996, Arthritis and rheumatism.

[70]  S. Straus,et al.  Postherpetic neuralgia--pathogenesis, treatment, and prevention. , 1996, The New England journal of medicine.

[71]  L. Mynors-Wallis,et al.  Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care , 1995, BMJ.

[72]  D. Sibley,et al.  Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. , 1993, The Journal of biological chemistry.

[73]  F. Holsboer,et al.  Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. , 1993, Endocrinology.

[74]  W A Ray,et al.  Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. , 1992, American journal of epidemiology.

[75]  R Dubner,et al.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. , 1992, The New England journal of medicine.

[76]  Patrick Onghena,et al.  Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies , 1992, Pain.

[77]  Wayne Katon,et al.  Adequacy and Duration of Antidepressant Treatment in Primary Care , 1992, Medical care.

[78]  T M Itil,et al.  Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. , 1990, The Journal of clinical psychiatry.

[79]  J. Davidson,et al.  Treatment of posttraumatic stress disorder with amitriptyline and placebo. , 1990, Archives of general psychiatry.

[80]  G H Guyatt,et al.  The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. , 1990, Annals of internal medicine.

[81]  G. Leijon,et al.  Central post-stroke pain — a controlled trial of amitriptyline and carbamazepine , 1989, Pain.

[82]  R. Dubner,et al.  Amitriptyline, but not lorazepam, relieves postherpetic neuralgia , 1988, Neurology.

[83]  P. Linkowski,et al.  24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. , 1987, The Journal of clinical endocrinology and metabolism.

[84]  R. Dubner,et al.  Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood , 1987, Neurology.

[85]  R. Dealy,et al.  The Pharmacological Treatment of Delusional Depression: Part II , 1986, Journal of clinical psychopharmacology.

[86]  D. Felson,et al.  A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. , 1986, Arthritis and rheumatism.

[87]  P. Benfield,et al.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. , 1986, Drugs.

[88]  D. Charney,et al.  Lithium carbonate augmentation of antidepressant treatment , 1984 .

[89]  C. Montigny,et al.  Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. , 1983, Archives of general psychiatry.

[90]  F. Petty,et al.  Specificity of the learned helplessness model of depression , 1982, Pharmacology Biochemistry and Behavior.

[91]  H. Merskey,et al.  Amitriptyline versus placebo in post-herpetic neuralgia , 1981, PAIN.

[92]  J. Green,et al.  Tricyclic antidepressant drugs block histamine H2 receptor in brain , 1977, Nature.

[93]  S. Snyder,et al.  Antidepressants and the muscarinic acetylcholine receptor. , 1977, Archives of general psychiatry.

[94]  R. O. Friedel,et al.  Prediction of tricyclic antidepressant response: a critical review. , 1976, Archives of general psychiatry.

[95]  J. Maas Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. , 1975, Archives of general psychiatry.

[96]  G. Cohen,et al.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.

[97]  A. Beck,et al.  The efficacy of antidepressant drugs. A review of research (1958-1972). , 1974, Archives of general psychiatry.

[98]  G. Klerman,et al.  Treatment of depression by drugs and psychotherapy. , 1974, The American journal of psychiatry.

[99]  R. Braithwaite,et al.  Plasma concentration of amitriptyline and clinical response. , 1972, Lancet.

[100]  K. Fuxe,et al.  The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. , 1971, Neuropharmacology.

[101]  S. Ross,et al.  Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. , 1969, European journal of pharmacology.

[102]  T. Hökfelt,et al.  Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. , 1969, European journal of pharmacology.

[103]  T. Hökfelt,et al.  Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. , 1969, European journal of pharmacology.

[104]  G. Roberts,et al.  The release of nucleotides, 5‐hydroxytryptamine and enzymes from human blood platelets during aggregation , 1968, The Journal of physiology.

[105]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[106]  Raminta Pranckute,et al.  Web of Science (WoS) and Scopus: The Titans of Bibliographic Information in Today's Academic World , 2021, Publ..

[107]  Takahiro A. Kato,et al.  Melatonin, Neuroprotective Agents and Antidepressant Therapy , 2016 .

[108]  Alec B. O’Connor Neuropathic Pain , 2012, PharmacoEconomics.

[109]  Adolfo Alonso-Arroyo,et al.  Which Data Base Should we Use for our Literature Analysis? Web of Science versus SCOPUS , 2011 .

[110]  Adolfo Alonso-Arroyo,et al.  Which data base should we use for our literature analysis? Web of Science versus SCOPUS. , 2011, Archivos de bronconeumologia.

[111]  S. Evers,et al.  EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force , 2009 .

[112]  Y. Swica,et al.  Proposal for the inclusion of misoprostol in the WHO model list of essential medicines , 2009 .

[113]  Report of the Quality Standards Subcommittee of the , 2010 .

[114]  Nancy D Berkman,et al.  Anorexia nervosa treatment: a systematic review of randomized controlled trials. , 2007, The International journal of eating disorders.

[115]  E. Montgomery Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. , 2007, Neurology.

[116]  Andrea Cipriani,et al.  Imputing missing standard deviations in meta-analyses can provide accurate results. , 2006, Journal of clinical epidemiology.

[117]  W. Weiner,et al.  Practice Parameter: Evaluation and in Treatment of Depression, Psychosis and Dementia Parkinson Disease (An Evidence-Based Review) , 2006 .

[118]  Wei Duan,et al.  Herb-drug interactions: a literature review. , 2005, Drugs.

[119]  D. Thomas,et al.  Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor , 2004, Psychopharmacology.

[120]  M. Meaney,et al.  The effects of chronic antidepressant treatment in an animal model of anxiety , 2004, Psychopharmacology.

[121]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[122]  P. O'Malley,et al.  Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. , 2000, The American journal of medicine.

[123]  J. Pancrazio,et al.  Inhibition of neuronal Na+ channels by antidepressant drugs. , 1998, The Journal of pharmacology and experimental therapeutics.

[124]  J. Kelly,et al.  The olfactory bulbectomized rat as a model of depression: an update. , 1997, Pharmacology & therapeutics.

[125]  E. Paykel,et al.  Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. , 1988, Journal of affective disorders.

[126]  S. Pond,et al.  First-Pass Elimination Basic Concepts and Clinical Consequences , 1984, Clinical pharmacokinetics.

[127]  F. Goodwin,et al.  Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. , 1975, Archives of general psychiatry.

[128]  S. Snyder,et al.  Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. , 1971, Molecular pharmacology.